Source link : https://www.newshealth.biz/health-news/new-gynecology-trials-could-your-patient-benefit/
Several new studies on gynecologic conditions have started in recent months. Perhaps one of your patients would be interested? Human papillomavirus (HPV) 16–positive, PD-L1–positive, persistent-recurrent or metastatic cervical cancer. Adults with this diagnosis who have progressed on standard first-line therapy of pembrolizumab (Keytruda) plus chemotherapy with/without bevacizumab (Avastin) may be eligible to join a phase […]
Author : News Health
Publish date : 2024-10-11 11:25:53
Copyright for syndicated content belongs to the linked Source.
Categories